Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-07-02T01:27:29.686Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunoadsorption and Absorptive Cell Separation

Published online by Cambridge University Press:  26 February 2011

Z. Yamazaki ,
F. Kanai ,
M. Hiraishi ,
Y. Idezuki ,
N. Inoue ,
N. Tsuda ,
H. Katoh ,
K. Ide ,
M. Umegae  and
K. Ohno
Z. Yamazaki
Affiliation:
University of Tokyo, 7-3-1, Hongo, Bunkyo-ku,Tokyo
F. Kanai
Affiliation:
University of Tokyo, 7-3-1, Hongo, Bunkyo-ku,Tokyo
M. Hiraishi
Affiliation:
University of Tokyo, 7-3-1, Hongo, Bunkyo-ku,Tokyo
Y. Idezuki
Affiliation:
University of Tokyo, 7-3-1, Hongo, Bunkyo-ku,Tokyo
N. Inoue
Affiliation:
University of Tokyo, 7-3-1, Hongo, Bunkyo-ku,Tokyo
N. Tsuda
Affiliation:
Asahi Medical Co., 1-1, Uchisaiwaicho, 1-chome, Chiyoda-ku, Tokyo, Japan
H. Katoh
Affiliation:
Asahi Medical Co., 1-1, Uchisaiwaicho, 1-chome, Chiyoda-ku, Tokyo, Japan
K. Ide
Affiliation:
Asahi Medical Co., 1-1, Uchisaiwaicho, 1-chome, Chiyoda-ku, Tokyo, Japan
M. Umegae
Affiliation:
Asahi Medical Co., 1-1, Uchisaiwaicho, 1-chome, Chiyoda-ku, Tokyo, Japan
K. Ohno
Affiliation:
Asahi Medical Co., 1-1, Uchisaiwaicho, 1-chome, Chiyoda-ku, Tokyo, Japan
Get access

Abstract

As a means of selectively removing pathogenic macromolecular substances, an affinity adsorbent or immunoadsorbent has been investigated in experimental and clinical studies on blood purification in the treatment of immune diseases. There are several affinity adsorbents currently available for clinical application. The authors developed physicochemical affinity adsorbents Immusorba IM-TR and IM-PH, whose experimental and clinical evaluations have been satisfactory in several immune diseases, such as rheumatoid arthritis, myasthenia gravis, systemic lupus erythematosus and multiple sclerosis.

Absorptive cell separation, for leucocyte-free blood transfusion or for cytapheresis, has been developed using a leucocyte removal filter, whose container has fine, long fibers of polyester which are densely packed. The filters Sepacell and Cellsorba are used for erythrocyte transfusion and cytapheresis, respectively. In experimental and clinical trials, they provide efficient removal of leucocytes. Erythrocytes can be recovered virtually without loss. Clinical evaluation is now being conducted.

In conclusion, the above-mentioned new methods provide promising immunomodulations for the treatment and for the clearification of pathphysiology of immune diseases.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 110: Symposium M – Biomedical Materials and Devices , 1987 , 729
Copyright
Copyright © Materials Research Society 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1) Terman, D.S. et al: Clin. Exp.Immunol. 24, 231, 1976.Google Scholar
2) Ray, P.K. et al: Cancer 49, 1800, 1982Google Scholar
3) Yamazaki, Z. et al: Trans. Am. Soc.Artif. Intern. Organs 28, 319, 1982.Google Scholar
4) Sato, T. et al: In: Therapeutic Plasma-pheresis (III), ed. Oda, T., p. 565, Schattauer Verlag Sttutgart 1982.Google Scholar
5) Shibuya, N. et al: In: Therapeutic plasmapheresis(IV), p 165, 1985.Google Scholar
6) Yamazaki, Z. et al: Trans. Am. Soc. Artif. Organs. 211, 1984.Google Scholar
7) Shibuya, N. et al: In: Current Practice in Therapeutic Plasmapheresis. 1985.Google Scholar
8) Heininger, K. et al: Artif. Organs 11, 332, 1987.Google Scholar
9) Behm, E. et al: Abstracts, International Symposium on Optimization of blood Purification, Rostock-Wornemuende, 1987.Google Scholar
10) Fujii, S et al: Biophys. Acta., 661, 342, 1981.Google Scholar
11) Tsuda, H. et al: Therapeutic Plasmapheresis, in press, 1987.Google Scholar
12) Tsubaki, et al: Biophys. Acta., 661, 342, in press, 1987.Google Scholar
13) Matsuda, T. et al: Biophys. Acta., 661, 342, in press, 1987.Google Scholar